T1	Participants 120 132	111 patients
T2	Participants 230 242	23 patients,
T3	Participants 371 429	23 patients were randomly allocated to an antibiotic group
T4	Participants 435 448	control group
T5	Participants 487 503	antibiotic group
T6	Participants 519 532	control group
T7	Participants 545 556	14 patients
